| # | Side effect | Count |
|---|---|---|
| 0 | PRURITUS | 322 |
| 1 | APPLICATION SITE PRURITUS | 224 |
| 2 | APPLICATION SITE ERYTHEMA | 220 |
| 3 | APPLICATION SITE PAIN | 218 |
| 4 | ERYTHEMA | 213 |
| 5 | CONDITION AGGRAVATED | 194 |
| 6 | OFF LABEL USE | 179 |
| 7 | SKIN DISCOLOURATION | 147 |
| 8 | RASH | 132 |
| 9 | SKIN IRRITATION | 112 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | APPLICATION SITE HYPERTROPHY | 6 | 0.4286 |
| 1 | CUTANEOUS T-CELL LYMPHOMA RECURRENT | 19 | 0.3016 |
| 2 | MYCOSIS FUNGOIDES RECURRENT | 8 | 0.2759 |
| 3 | APPLICATION SITE FISSURE | 12 | 0.1333 |
| 4 | CUTANEOUS T-CELL LYMPHOMA STAGE III | 2 | 0.0870 |
| 5 | APPLICATION SITE WOUND | 13 | 0.0788 |
| 6 | APPLICATION SITE CELLULITIS | 5 | 0.0746 |
| 7 | APPLICATION SITE ATROPHY | 2 | 0.0606 |
| 8 | CUTANEOUS T-CELL LYMPHOMA STAGE IV | 2 | 0.0556 |
| 9 | MYCOSIS FUNGOIDES | 34 | 0.0413 |